Abstracts submission

If the Poster Presenter is registered with an in-person registration ticket and an abstract has been confirmed for an in-person presentation and they then decide to attend virtually at a later date, then the only presentation opportunity will be via the video (MP4) file preloaded with the digital poster. 

If the Poster Presenter is registered with a virtual registration ticket and an abstract has been confirmed for a virtual presentation and they then decide to attend in-person at a later date, then it is at the discretion of the Programme Committee as to whether the presentation type will be changed from video (MP4) file to traditional poster. 

• All abstract submitters who are accepted must complete, sign and return a conflict of interest link. A link will be sent in the abstract outcome notification if the abstract is accepted. The link must be completed within 72 hours from receipt. When submitting an abstract with multiple authors, only the presenting author needs to complete the declaration of conflict of interest. We do not require the conflict of interest from all authors of the same paper.  If you have any queries please contact our WMS Accreditation Manager, on [email protected].
• There is no fee to submit an abstract. A WMS Membership is not required to submit an abstract unless applying for a Fellowship.
• To submit an abstract the author will have to use a personalised link in the Registration confirmation email. Please do not use anyone else's confirmation link to submit your abstract or you will overwrite their submission.
• To submit an abstract from a sponsoring, exhibiting or other industry organisation, the presenter’s registration must be from within those organisations global allocated registration ticket allowance.
• Upon submission, indicate one of the topics from the list that best describes the content of the abstract.
• Abstracts must be written in English.
• The title must have a maximum of 150 characters and be written in sentence case - all disease names in Camel Case.
• No spaces before or after names, organisations, or countries please.
• Maximum 2,000 characters (including spaces and excluding title and authors information).
• A maximum of 20 co-authors per abstract are allowed. If more co-authors have contributed, these should be summarily stated as a Study Group as the last co-author and can later be displayed on the poster or appropriately be acknowledged during an oral. 
• References and credits are not to be included in the abstract, nor subheadings (background, methods, results, etc. specifically labeled), graphical files, tables, figures or keywords. Note that all subheadings in abstracts will automatically be deleted by the programme committee.
• Remember to check if you are eligible for a Fellowship and apply during the registration process.
• Abstracts cannot be submitted by fax, hard copy or e-mail.
• Within reason, there is no limit to the number of abstracts that can be submitted.
• It is the presenting authors responsibility to make the appropriate potential conflict of interest disclosure acknowledgement on their poster/slide as indicated during the abstract submission process. It is the presenting authors responsibility to notify the organisers of any change to this status between submission and the congress. Slide templates are available Here.
• The submitter will receive all correspondence concerning the abstract including acknowledgement of receipt of the submission and is responsible for informing co-authors and agencies assisting with uploading presentations of the status of the abstract.
• The submitter will have access to the abstract in Save Draft status via the submisison portal until the abstract is Submitted or the relevant abstract deadline has passed. The abstract will not auto submit if in Draft, after the deadline has passed.
• In cases where the abstract is NOT accepted, participants will be contacted promptly. Delegates will have the opportunity to attend the congress or cancel their registration in full.
• It is the author’s responsibility to submit a correct abstract; if accepted, any errors in spelling, grammar, or scientific fact may be reproduced as typed by the author. The Programme Committee reserves the right to shorten the abstract title to allow its publication in the congress programme and Neuromuscular Disorders Journal and edit the content to remove acknowledgements and misspellings identified by the Programme Committee.
• Please refer to the Dates page for fellowship deadline and payment dates. Payment is post-congress.
• Should you need to withdraw your abstract, please contact [email protected] and we will be able to guide you through whether this is possible, depending on the stage of the process.
• PLEASE read and check the abstract before submission